Protein Biomarker Identified for Aggressive Neuroendocrine Carcinomas Diagnosis
New research is guiding the development of blood tests to detect and monitor responses to therapies in neuroendocrine carcinomas patients.
Read More
Search Results for: lung cancer
Personalis Gets Medicare Coverage for Genomic Tumor Profiling Assay
The assay received a final Medicare coverage determination, providing access for Medicare and Medicare Advantage beneficiaries.
Read More
New ChromaCode Collaboration to Improve NSCLC Biomarker Testing Access
ChromaCode will collaborate with Tennessee Oncology to test the performance of ChromaCode’s HDPCR NSCLC biomarker assay.
Read More
Precision Medicine Will Advance Through Widespread Adoption of NGS
Next-generation sequencing is at the forefront of the precision medicine revolution, offering the promise to empower tailored patient care.
Read More
Illumina Unveils Liquid Biopsy Assays for Comprehensive Genomic Profiling of Solid Tumors
The TruSightf Oncology 500 ctDNA v2 enables comprehensive genomic profiling of ctDNA from blood when tissue testing is not available.
Read More